Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, August 19 at 2:00 PM EDT

Register Free →

Search

Top

COMPREMIUM AG

UEI: D2WTHY311845CAGE: SPHB0

COMPREMIUM AG is a federal contractor, registered under UEI D2WTHY311845 and CAGE code SPHB0. It has been awarded $300,400 across 3 federal contracts. Primary work spans Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) and Unknown NAICS. Top awarding agencies include National Aeronautics And Space Administration (nasa) and Department Of Health And Human Services (hhs).

Contact Information

Registration and classification details

Websitehttps://www.compremium.ch

Address123 Main St, City, ST 12345

Registration

UEI Code

D2WTHY311845

CAGE Code

SPHB0

Entity Structure

Corporate Entity (Not Tax Exempt)

Established

N/A

Business Classifications

2X

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

Key Performance Metrics

Awards Count

0

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency

National Aeronautics And Space Administration (nasa)$250.4K83.4%

Department Of Health And Human Services (hhs)$50.0K16.6%

Awards by NAICS

541712 - Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)$250.4K83.4%

- Unknown NAICS$50.0K16.6%

Awards by Agency Over Time

Awards by Place of Performance

Open opportunities in COMPREMIUM AG's top NAICS codes and agencies

DDDPlus Software Licensing and SupportThe contract entails the provision of five individual Standard licenses for DDDPlus software, covering full delivery, installation, and compatibility testing to ensure seamless integration with existing systems. License administration will be maintained throughout a four-year term, including ongoing support and compliance management. The work is performance-based with the place of performance located in Silver Spring, Maryland, under a subcontract structure, and falls under the NAICS code 511210 for software publishing. The Department of Health and Human Services is the contracting organization, with a response deadline set for August 14, 2026, and the solicitation was posted on August 4, 2026. All activities must align with federal procurement standards and deliverables must meet technical and operational requirements specified in the agreement.

Department Of Health And Human Services

POSTED

DEADLINE

GastroPlus Software Licensing and SupportThe contract awards the supply and ongoing support of 20 Standard licenses for GastroPlus software over a four-year period, encompassing full delivery, installation, and verification of compatibility with FDA systems. The provider is responsible for ensuring seamless integration into existing infrastructure and managing all aspects of license administration throughout the term. Performance is required to occur at the designated location in Silver Spring, Maryland, with the work falling under NAICS code 511210 for software publishing. The opportunity was posted on August 4, 2026, and responses are due by August 14, 2026, with the contracting entity being the Department of Health and Human Services. This subcontract supports critical regulatory and scientific operations that rely on GastroPlus for pharmacokinetic and pharmacodynamic modeling within federal health and safety contexts.

Department Of Health And Human Services

POSTED

DEADLINE

Notice of Sole Source: GastroPlus PBPK and PBBM modeling platform subscription

Solicitation # 7571TE26Q00153

The U.S. Food and Drug Administration, through the Department of Health and Human Services, intends to sole-source a firm fixed-price contract to Simulations Plus Inc. for twenty GastroPlus and five DDDPlus software licenses, used for physiologically based pharmacokinetic and physiologically based biopharmaceutics modeling in support of generic drug research. The contract spans a base year from September 1, 2026, to August 31, 2027, with up to three one-year option periods extending through August 31, 2030. Performance will occur at the FDA’s White Oak campus in Silver Spring, Maryland. The acquisition is conducted under RFO 12, allowing for non-competitive procurement of commercial products, and no set-aside applies. Responses are due by August 14, 2026, and any interested party may submit a capability statement to demonstrate their ability to supply the exact software licenses as the original equipment manufacturer or authorized reseller, which the government will review solely to determine whether competitive procurement is warranted. The contract requires the vendor to provide standard individual licenses, with no auto-renewals permitted unless explicitly authorized. Acceptance of deliverables will be conducted by the Contracting Officer’s Representative within 30 working days of delivery, verifying software functionality, compatibility with FDA systems, and compliance with technical requirements. Invoicing must be submitted electronically through the Treasury’s Invoice Processing Platform, and all invoices must include detailed supporting documentation for labor, materials, and costs. The government retains the right to reject nonconforming deliveries and will not pay for services that fail to meet agreed standards. Clauses from the FAR and HHSAR govern payment, representation, whistleblower rights, anti-lobbying, accessibility, and dispute resolution, with federal regulations taking precedence over any vendor terms. The Contracting Officer and Contract Specialist are the primary points of contact, and all vendors must be actively registered in SAM at the time of submission.

Department Of Health And Human Services

POSTED

DEADLINE

CAM ASSEMBLY, LOWER,

Solicitation # SPE7M4-26-T-299C

The contract pertains to the procurement of a CAM ASSEMBLY, LOWER, identified by part number 74A430615-1001 and NSN 1710-01-478-1569, with a total quantity of 21 units at a unit price of $21.00, resulting in a total contract value of $441.00. Delivery is required within 590 days from the contract award, with FOB origin terms and final inspection and acceptance occurring at the destination. The item is classified as a critical application component, subject to stringent quality verification standards, including zero non-conformances in sampling under MIL-STD-1916 or comparable zero-based plans, with critical, major, and minor attributes assigned specific verification levels or AQLs. Packaging must align with ASTM D3951 and MIL-STD-129 labeling requirements, prioritizing DLA Master List of Technical and Quality Requirements over any conflicting standards, and palletization must comply with RP001 DLA packaging guidelines. The contractor must maintain CMMC Level 2 cybersecurity self-assessment compliance and adhere to all applicable technical and quality references listed in the DLA Master List. The delivery destination is DLA Distribution San Diego at 3581 Cummings Road, Building 3581, San Diego, CA 92136-3581, with a required ship date of June 18, 2026, and an original delivery deadline of February 10, 2029. The solicitation number is SPE7M4-26-T-299C, with a response deadline of August 14, 2026, issued under NAICS code 541712 by the Department of Defense’s Fluid Handling Division, and is managed by point of contact Rory O’Reilly.

FLUID HANDLING DIVISION

POSTED

DEADLINE

Unable to Decompose Subcontract OpportunitiesDue to a system error, the prime contract details necessary to identify or structure subcontract opportunities could not be retrieved, rendering all subcontracting analysis unavailable at this time. The solicitation is designated as a subcontract under the Department of Health and Human Services, with a posted date of August 3, 2026, and a response deadline of August 18, 2026. The place of performance is listed as Bethesda, Maryland, with a zip code of 20892, though no specific office address, point of contact, or set-aside information is provided. The NAICS code is marked as NA, and the agency and organizational designations are identical, indicating an internal system limitation. Despite the absence of actionable data for suppliers, the opportunity remains live in the system with a public view link available for reference.

Department Of Health And Human Services

POSTED

DEADLINE

Antioxidant Therapy for Smith-Lemli-Opitz Syndrone

Solicitation # NICHD-08610

The contract pertains to the development and implementation of antioxidant therapy for Smith-Lemli-Opitz Syndrome, a rare genetic disorder characterized by multiple congenital anomalies and metabolic dysfunction. The solicitation, issued under NICHD-08610 by the Department of Health and Human Services through its National Institutes of Health, invites proposals aimed at advancing targeted antioxidant interventions to mitigate the pathological effects of the condition. The opportunity was posted on August 3, 2026, with responses due by August 18, 2026, at 2:00 PM Eastern Time. The work is expected to be performed in Bethesda, Maryland, consistent with the research infrastructure of the NIH campus. All proposals must be submitted through the SAM.gov portal and should address scientific rigor, feasibility, and potential clinical impact. The primary point of contact for inquiries is Niamh Cawley, with Chung Huang as the secondary contact, both reachable via NIH email addresses. The contracting activity falls under the Department of Health and Human Services with no set-aside provisions specified, and no NAICS code is assigned, indicating flexibility in contractor categorization. Interested parties should ensure adherence to deadlines and submission requirements outlined on the official UI link linked in the posting.

Department Of Health And Human Services

POSTED

DEADLINE

BUSHING-TORQUE ARM,

Solicitation # SPE7L3-26-T-144T

The contract is for the procurement of 38 units of a Bushing-Torque Arm, identified by NSN 1710-01-478-1872 and critical part number 74A430625-2001, sourced from approved manufacturers The Boeing Company and Safran Landing Systems Canada Inc. This is a critical application item procured under solicitation SPE7L3-26-T-144T, issued by the Defense Logistics Agency Land and Maritime, with delivery required to DLA Distribution San Diego at 3581 Cummings Road, Building 3581, San Diego, CA 92136-3581. The unit price is $38.00 per unit, with FOB Origin terms, zero quantity variance allowed, and delivery required within 347 days of contract award, with an original delivery date of April 15, 2026, and an early need ship date of February 4, 2025. All supplies must comply with the DLA Master List of Technical and Quality Requirements, which override any conflicting standards such as ASTM D3951, and must be packaged, marked, and labeled per MIL-STD-129 and RP001, with palletization following DLA packaging standards. Sampling for inspection must adhere to MIL-STD-1916, ASQ H1331 Table 1, or an equivalent zero-based plan, with unspecified attributes treated as major and zero non-conformances required unless otherwise stated. Inspection and acceptance occur at destination under FAR 52.246-2. The item is exempt from additive manufacturing unless explicitly authorized. The contractor must electronically submit invoices and receiving reports via WAWF, comply with all cybersecurity mandates including DFARS 252.204-7012 and NIST SP 800-171, and adhere to the prohibition of hexavalent chromium, covered telecommunications equipment, and communist Chinese military company items. The Berry Amendment applies, requiring domestic origin materials above $150,000, and safety data sheets must be provided prior to award. Contractors must be registered in SAM and AMPS for DLA shipments, and all bids must be submitted via DIBBS by August 13, 2026. The contract includes mandatory clauses covering whistleblower protections, cyber incident reporting

LAND SUPPLIER OPNS VEHICLE SPT

POSTED

DEADLINE

Notice of Intent / Sole Source Solid Waste

Solicitation # 75H71026Q00223

The Navajo Area Indian Health Service, Shiprock Service Unit, intends to award a sole-source, firm-fixed-price contract to Navajo Sanitation for solid waste collection services at the Dzilth-Na-O-Dith-Hle Health Center in Bloomfield, New Mexico, with performance beginning September 1, 2026, and ending August 31, 2027. The procurement is justified under unusual and compelling urgency due to the contractor’s unique, uninterrupted history of providing essential waste management services at the facility, ensuring continuity of operations critical to patient care. The North American Industry Classification System code is 562111, with a small business size standard of $47 million in annual revenue. No competitive solicitation will be issued unless a respondent submits clear and convincing evidence that competition would benefit the government. Responses must be submitted in writing as a capability statement by August 17, 2026, at 10:00 a.m. MST, and must not include proprietary, classified, confidential, or sensitive information. The government is not obligated to respond to or acknowledge submissions, and failure to receive affirmative responses will result in contract award without further notice. All information provided may be used in future solicitations if competition is pursued, and any resulting solicitation will be publicly announced on SAM.gov. The point of contact for inquiries is Ken Parrish, Purchasing Agent, reachable at ken.parrish@ihs.gov.

Department Of Health And Human Services

POSTED

DEADLINE

Trailblazers CDRL Services

FA8811 Assrd Acss To Spc Ssc/aak-La

POSTED

DEADLINE

in about 22 hours

Explosives Detection & Threat Mitigation Technology Development

Sci Technology Acq Division

POSTED

DEADLINE

OHS Region 11 Training and Technical Assistance Network

Solicitation # 7571MN26C00013

The Department of the Interior’s existing contract with ICF Incorporated, LLC, numbered 140D0425C0027, has been administratively transferred to the Department of Health and Human Services under a new task order, 7571MN26C00013, effective July 1, 2026. This transfer is purely administrative and does not alter the original contract’s scope of work, deliverables, ultimate value, or period of performance. The work continues under the same terms and conditions, now managed by HHS to support the OHS Region 11 Training and Technical Assistance Network, with performance based in Reston, Virginia, and administrative oversight from Washington, DC. The contract, classified under NAICS code 541611, remains unrestricted with no set-aside requirements and is fully maintained under the original contractor’s responsibility. Point of contact for inquiries includes Carla Carter and Hamed Hassanzadeh Makou at HHS.

Department Of Health And Human Services

POSTED

about 1 month ago

DEADLINE

Pax Silica Artificial Intelligence Assistance Project

Solicitation # DFOP0019182

The Pax Silica Artificial Intelligence Assistance Project, funded through foreign assistance from the Pax Fund and issued under solicitation number DFOP0019182 by the Department of State’s Bureau of Oceans - Interior Environmental - Scientific, aims to establish a first-of-its-kind global platform to secure the AI supply chain through cryptographic cargo verification, AI-driven risk assessment, and expedited compliance processes. This initiative will create a Silicon Highway—a digital-physical corridor connecting partner countries—to enhance logistics efficiency and supply chain integrity by enabling trusted provenance tracking and pre-approved accelerated processing from the earliest stages of the AI hardware and software supply chain. The program is designed to build resilience against tampering, counterfeiting, and disruptions in critical AI components by institutionalizing a globally recognized credentialing system. The project is open to applicants responding by the deadline of August 20, 2026, with all proposals submitted through the grants.gov portal. The Bureau of Oceans - Interior Environmental - Scientific is the responsible agency, and while the place of performance is not specified, the point of contact is available through the provided phone number. The Department of State retains full rights to any intangible property developed under this initiative, in accordance with federal regulations. Participation is expected to involve international collaboration, technical innovation, and the integration of advanced digital tools to ensure transparency and security across the global AI supply chain.

Bureau Of Oceans - Interior Environmental - Scientific

POSTED

about 1 month ago

DEADLINE

AI-Integrated Biologic Development PartnerThe contract involves a collaboration with Los Alamos National Laboratory to integrate artificial intelligence-designed targeting molecules into the NanoFET platform, aiming to advance next-generation immunotherapies. This subcontract is focused on developing novel biologic therapies by leveraging AI-driven molecular design to enhance precision targeting within the immune system, with the NanoFET platform serving as the delivery and activation mechanism. The work will be performed at the Los Alamos facility with a zip code of 87545, and all activities are expected to align with DOE’s mission in cutting-edge biomedical innovation. The solicitation was posted on June 17, 2026, with a response deadline of December 18, 2026, and falls under the NAICS code 541712 for research and development in the physical, engineering, and life sciences. The contracting entity is Triad, a Department of Energy contractor, and the agreement is structured as a subcontract, indicating the work is part of a larger program driven by federal R&D priorities. There is no set-aside designation specified, and the effort is open to qualified entities capable of advancing AI-biology integration, with an emphasis on scalable, clinically viable immunotherapy platforms.

Triad - DOE Contractor

POSTED

about 2 months ago

DEADLINE

Portfolio Management System (OPS)

Solicitation # 7571MN26F80053

The Department of the Interior’s contract GS35F523BA/140D0422F0466, originally awarded to the Community Development Institute on May 11, 2022, for the Portfolio Management System (OPS), has been administratively transferred to the Department of Health and Human Services under the new contract number GS35F523BA/7571MN26F80053, effective June 12, 2026. This transfer does not modify any existing terms, including the ultimate contract value or the period of performance, and all scope of work, deliverables, and contractual obligations remain unchanged. The contract, identified by NAICS code 541511, is managed by HHS with the primary point of contact being Amber Harris at amber.harris@hhs.gov, and the work is performed in Madison, Wisconsin, while the contracting office is located in Washington, D.C. The contract notice was posted on June 15, 2026, and the change is purely administrative, with no impact on the contractor or the execution of the project.

Department Of Health And Human Services

POSTED

about 2 months ago

DEADLINE

NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)

Solicitation # PA-27-102

This solicitation supports Small Business Technology Transfer (STTR) grants through the National Institutes of Health to fund research and development projects that advance innovative technologies with potential for commercialization, requiring a formal collaboration between a U.S.-owned small business and a nonprofit research institution. The award is made solely to the small business, regardless of where the principal investigator is employed, and projects must align with the missions of NIH, CDC, or FDA components. Funding is available for Phase I, Phase II, Direct to Phase II, and Fast-Track applications, with Fast-Track allowing combined Phase I and II review to streamline the process. Direct to Phase II is an option for businesses that have already demonstrated technical merit without prior Phase I funding, provided the application is submitted as a new proposal, not a renewal. Only one Phase II award is permitted per Phase I project, and Phase IIB Strategic Breakthrough applications must go through a separate solicitation. Applications must focus on feasibility or R&D that supports public health goals and are subject to restrictions on clinical trials, which are not permitted under this NOFO if exclusively aligned with specific NIH institutes including NIAID, NIAMS, NIDCR, NIDDK, NIMHD, NCATS, and ORIP. The funding opportunity is part of the broader SBIR/STTR mandate, which requires NIH to set aside 0.45% of its extramural budget for STTR, ensuring support for small businesses with fewer than 500 employees. Applicants are encouraged to consult with program staff prior to submission to ensure alignment with funding priorities and to use the Assignment Request Form to suggest an appropriate awarding component, though such identification is not mandatory. The solicitation closes on August 5, 2026, and information on program details, priorities, and frequently asked questions is available through the NIH Seed Fund portal and related government strategies including the Make Our Children Healthy Again initiative.

Department of Health and Human Services

POSTED

DEADLINE

NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)

Solicitation # PA-27-100

This funding opportunity supports U.S. small businesses in advancing early-stage research and development toward commercialization through the SBIR program, administered by the National Institutes of Health, Centers for Disease Control and Prevention, and Food and Drug Administration. Eligible small businesses must be U.S.-owned and operated with fewer than 500 employees and are expected to lead the majority of the technical effort, with the principal investigator primarily employed by the business. The program offers Phase I grants to establish technical feasibility, Phase II grants to advance development toward market readiness, and two special pathways: Direct to Phase II for projects with prior proof of concept but no prior Phase I award, and Fast-Track for combined Phase I and Phase II submissions reviewed concurrently to accelerate progress. All awards are granted to the small business, and commercialization must be pursued using non-SBIR funds after Phase II. The scientific scope must align with the missions of participating NIH, CDC, or FDA components, focusing on health improvement and public health innovation, with applicants encouraged to consult specific institute priorities and the White House’s Make Our Children Healthy Again Strategy. While clinical trials are permitted, they are explicitly excluded if the application aligns solely with certain NIH institutes or all FDA centers, making alignment critical for responsiveness. Applications must be submitted through the designated portal by the deadline, and while applicants are not required to specify an awarding component during submission, consultation with program staff beforehand is strongly advised to ensure proper alignment. The solicitation operates under a complete small business set-aside mandate and is open to new applications only, with no renewals accepted for Direct to Phase II submissions.

Department of Health and Human Services

POSTED

DEADLINE

SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)

Solicitation # PAR-27-098

The Commercialization Readiness Pilot (CRP) program, issued under PAR-27-098, provides late-stage research and development funding and technical assistance to U.S. small business concerns that have previously received an NIH SBIR or STTR Phase II award or a Phase IIB Strategic Breakthrough award. This initiative is designed to bridge the gap between Phase II completion and full commercialization by supporting activities that require significant outsourcing, such as regulatory strategy, intellectual property development, manufacturing optimization, pre-clinical product development, and clinical trials—though not all NIH institutes accept clinical trial proposals. The program permits substantial outsourcing to contract research organizations but requires the small business to maintain active oversight and management of all scientific, financial, and administrative aspects of the work, with justified budget allocations reflecting this role. CRP funding cannot cover FDA filing fees or include separate Technical and Business Assistance (TABA) funds. Eligible applicants must be small business concerns under 500 employees meeting SBA size standards, and proposals must align with the mission of participating NIH components. The solicitation explicitly excludes applications that propose clinical trials solely aligned with certain NIH institutes, including NHLBI, NIAID, NIDDK, and others listed, which do not accept such trials under this program. Applications are limited to Type 1 new submissions, and prior Phase II funding is mandatory for eligibility. Applicants are strongly encouraged to consult with NIH program staff before submitting to ensure alignment with the most appropriate funding mechanism, as the Phase IIB Strategic Breakthrough program (PA-27-101) may be better suited for some projects with matching fund requirements. The solicitation is active through August 5, 2026, under a total small business set-aside, and further details are available through the NIH SBIR/STTR portal.

Department of Health and Human Services

POSTED

DEADLINE

Coordinated Sentinel Surveillance and Discovery for Emerging Human PathogensThe Centers for Disease Control and Prevention is forecasting a contract titled Coordinated Sentinel Surveillance and Discovery for Emerging Human Pathogens, set to be posted on May 25, 2026, under NAICS code 541712, which covers research and development in the physical, engineering, and life sciences. The primary objective is to establish a coordinated network for early detection and characterization of emerging human pathogens through sentinel surveillance systems and advanced discovery methods. This initiative aims to strengthen national capabilities in identifying novel infectious agents before they escalate into widespread public health threats, leveraging real-time data collection, genomic sequencing, and analytical tools across diverse geographic and demographic settings. The program will rely on collaboration with healthcare facilities, laboratories, and public health agencies to ensure rapid response and data sharing. The point of contact for this opportunity is Latoshia Gray, serving as the Program Point of Contact, with the contracting officer position listed as to be determined. All communications and submissions should be directed to lqg8@cdc.gov. The place of performance and specific location details have not been designated, indicating flexibility in geographic scope to support a nationwide or multi-region surveillance infrastructure. This forecast signals CDC’s intent to invest in proactive pathogen monitoring systems that integrate clinical, environmental, and genomic data streams to enhance readiness for future outbreaks. While no set-aside provisions are specified, the solicitation is expected to attract qualified research organizations, academic institutions, and private sector entities with expertise in infectious disease surveillance, bioinformatics, and public health diagnostics.

Centers For Disease Control And Prevention

POSTED

DEADLINE